Xilio Therapeutics Grants 107,060 Stock Options to 3 New Hires

Xilio Therapeutics, Inc. announced that it granted non-qualified stock options to purchase 107,060 shares of its common stock to three new employees, effective July 1, 2026. The options have an exercise price of $9.22 per share, matching the closing price on the grant date. These options will vest 25% on the first anniversary of employment, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service.